Sensitivity of cutaneous chronic myelomonocytic leukaemia lesions to hypomethylating treatment

Eur J Dermatol. 2017 Oct 1;27(5):540-542. doi: 10.1684/ejd.2017.3068.

Affiliations

¹ Institute of Hematology and Hemato-Oncology Research Centre (CREO), University of Perugia, Perugia, Italy.
² Santo Spirito Hospital, Pescara, Department of Hematology, Bone Marrow Transplant Center, Pescara, Italy.

PMID: 29084640
DOI: 10.1684/ejd.2017.3068

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Administration, Cutaneous
Antimetabolites, Antineoplastic / therapeutic use*
Azacitidine / therapeutic use*
Humans
Leukemia, Myelomonocytic, Chronic / drug therapy*
Leukemia, Myelomonocytic, Chronic / genetics
Leukemia, Myelomonocytic, Chronic / pathology
Lip Neoplasms / drug therapy
Lip Neoplasms / genetics
Lip Neoplasms / pathology
Lip Neoplasms / radiotherapy
Male
Middle Aged
Skin Neoplasms / drug therapy*
Skin Neoplasms / genetics
Skin Neoplasms / pathology

Substances

Antimetabolites, Antineoplastic
Azacitidine